Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells

Fig. 3

Effects of MR16-1 on iron indices and pro-inflammatory cytokines in the LC-06-JCK mouse model. a Murine hepcidin levels, b murine ferritin levels, c murine TNF-α levels, d murine IL-1β levels, and e murine IL-6 levels were measured in mice treated for 5 weeks. Results are the mean + SD for 19–20 mice in each group. * P < 0.05, age-matched NTB group versus TB group (Wilcoxon test); # P < 0.05, TB group versus MR16-1 group (Wilcoxon test)

Back to article page